{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:09Z","timestamp":1793731029742,"version":"4.6.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac ischemia, a predominant cause of heart failure, is marked by profound mitochondrial dysfunction, dysregulated ion homeostasis, and maladaptive cellular remodeling, all of which compromise cardiac performance. The mitochondrial inner membrane protein Leucine zipper-EF-hand containing Transmembrane Protein 1 (Letm1), implicated in Wolf-Hirschhorn Syndrome, is essential for mitochondrial function. Although genetic alterations in Letm1 are linked to cardiomyopathies, its specific contributions to cardiac pathophysiology, particularly in the context of ischemic heart disease, remain poorly defined. This study aims to elucidate the role of Letm1 in ischemic cardiac pathology and its mechanistic impact on cardiomyocyte function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Letm1 expression was assessed in human and murine models of heart failure due to ischemic cardiomyopathy (ICM) and cardiac hypertrophy. Letm1 was overexpressed in neonatal rat ventricular cardiomyocytes, adult mouse cardiomyocytes, and human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to study mitochondrial function (Seahorse assays), structural and molecular remodeling (fluorescence microscopy, transmission electron microscopy (TEM), qPCR, immunoblotting), transcriptomic\/proteomic profiles, calcium handling and electrophysiology (patch-clamp), autophagic flux (Bafilomycin A1, LC3-RFP-GFP), and cell survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Letm1 was markedly upregulated in ICM in both human and murine hearts, but unchanged in hypertrophic heart failure. Overexpression of Letm1 in cardiomyocytes resulted in profound mitochondrial dysfunction, including downregulation of oxidative phosphorylation (OXPHOS) genes, impaired membrane potential, reduced ATP output, increased proton leak, and elevated ROS levels. A metabolic shift toward glycolysis was observed, accompanied by reduced fatty acid oxidation. Electron microscopy revealed mitochondrial fragmentation, mitophagic vesicles, and sarcomeric disarray. Transcriptomic and proteomic analyses highlighted dysregulation of genes linked to mitochondrial organization, ion transport, and autophagy. Electrophysiologically, Letm1 reduced L-type Ca\n                      <jats:sup>2+<\/jats:sup>\n                      current density and significantly shortened action potential duration, leading to impaired contractility. Letm1 overexpression activated upstream autophagy regulators (AMPK, ULK1) and enhanced LC3-II and p62 accumulation, but autophagic flux was impaired, as confirmed by LC3-RFP-GFP reporter and exacerbated by Bafilomycin A1 treatment. This dysregulated autophagy was coupled with mitochondrial stress, increased apoptosis (cleaved caspases), and reduced cardiomyocyte viability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study indicates that Letm1 upregulation drives mitochondrial dysfunction, electrophysiology alterations, and activation of autophagy and apoptosis, culminating in cardiomyocyte injury in ischemic cardiomyopathy. By disrupting OXPHOS, calcium handling, and cell survival pathways, Letm1 contributes to ischemic remodeling and cardiac dysfunction. Targeting Letm1 presents a promising therapeutic strategy to alleviate ischemic damage and preserve cardiac function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p>This graphical abstract illustrates the multifaceted effects of elevated levels of Leucine zipper-EF-hand-containing transmembrane protein 1 (Letm1) on cardiomyocyte function. Increased Letm1 disrupts mitochondrial oxidative phosphorylation (OXPHOS), leading to energy supply deficits, mitochondrial dysregulation, and impaired ion channel activity. These alterations contribute to electrophysiological deficits and compromise cardiac action potential. Simultaneously, mitochondrial dysfunction accelerates autophagy and apoptosis, further diminishing cell survival. Together, these mechanisms drive contractile dysfunction in neonatal rat ventricular cardiomyocytes (NRVCMs), highlighting a critical role for Letm1 in cardiac pathophysiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02378-7","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:45:39Z","timestamp":1755920739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Elevated levels of Letm1 drives mitochondrial dysfunction and cardiomyocyte stress-mediated apoptosis in cultured cardiomyocytes"],"prefix":"10.1186","volume":"23","author":[{"given":"Anushka","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Weirauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan Kumar","family":"Baral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Steier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Borlepawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia S.","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf Y.","family":"Rangrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"2378_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol. 2022;80:2361\u201371. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.005.","journal-title":"J Am Coll Cardiol"},{"key":"2378_CR2","doi-asserted-by":"publisher","first-page":"e9349","DOI":"10.7759\/cureus.9349","volume":"12","author":"MA Khan","year":"2020","unstructured":"Khan MA, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12:e9349. https:\/\/doi.org\/10.7759\/cureus.9349.","journal-title":"Cureus."},{"key":"2378_CR3","doi-asserted-by":"publisher","first-page":"112086","DOI":"10.1016\/j.celrep.2023.112086","volume":"42","author":"B Simonson","year":"2023","unstructured":"Simonson B, et al. Single-nucleus RNA sequencing in ischemic cardiomyopathy reveals common transcriptional profile underlying end-stage heart failure. Cell Rep. 2023;42:112086. https:\/\/doi.org\/10.1016\/j.celrep.2023.112086.","journal-title":"Cell Rep"},{"key":"2378_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7150\/ijbs.76223","volume":"19","author":"X Chang","year":"2023","unstructured":"Chang X, et al. Molecular mechanisms of mitochondrial quality control in ischemic cardiomyopathy. Int J Biol Sci. 2023;19:426\u201348. https:\/\/doi.org\/10.7150\/ijbs.76223.","journal-title":"Int J Biol Sci"},{"key":"2378_CR5","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1111\/bph.14431","volume":"176","author":"BY Nguyen","year":"2019","unstructured":"Nguyen BY, et al. Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials. Br J Pharmacol. 2019;176:4302\u201318. https:\/\/doi.org\/10.1111\/bph.14431.","journal-title":"Br J Pharmacol"},{"key":"2378_CR6","doi-asserted-by":"publisher","unstructured":"Kuznetsov AV, et al. The role of mitochondria in the mechanisms of cardiac Ischemia-Reperfusion injury. Antioxid (Basel). 2019;8. https:\/\/doi.org\/10.3390\/antiox8100454.","DOI":"10.3390\/antiox8100454"},{"key":"2378_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.mito.2011.06.001","volume":"11","author":"B Kadenbach","year":"2011","unstructured":"Kadenbach B, Ramzan R, Moosdorf R, Vogt S. The role of mitochondrial membrane potential in ischemic heart failure. Mitochondrion. 2011;11:700\u20136. https:\/\/doi.org\/10.1016\/j.mito.2011.06.001.","journal-title":"Mitochondrion"},{"key":"2378_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","volume":"117","author":"S Cadenas","year":"2018","unstructured":"Cadenas S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med. 2018;117:76\u201389. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.01.024.","journal-title":"Free Radic Biol Med"},{"key":"2378_CR9","doi-asserted-by":"publisher","first-page":"825468","DOI":"10.1155\/2015\/825468","volume":"2015","author":"MA Sazonova","year":"2015","unstructured":"Sazonova MA, et al. Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta. Biomed Res Int. 2015;2015:825468. https:\/\/doi.org\/10.1155\/2015\/825468.","journal-title":"Biomed Res Int."},{"key":"2378_CR10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1161\/CIRCRESAHA.118.310082","volume":"122","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. Circ Res. 2018;122:1460\u201378. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.310082.","journal-title":"Circ Res"},{"key":"2378_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00395-007-0666-z","volume":"102","author":"C Maack","year":"2007","unstructured":"Maack C, O\u2019Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol. 2007;102:369\u201392. https:\/\/doi.org\/10.1007\/s00395-007-0666-z.","journal-title":"Basic Res Cardiol"},{"key":"2378_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","volume":"121","author":"DA Eisner","year":"2017","unstructured":"Eisner DA, Caldwell JL, Kistamas K, Trafford AW. Calcium and Excitation-Contraction coupling in the heart. Circ Res. 2017;121:181\u201395. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310230.","journal-title":"Circ Res"},{"key":"2378_CR13","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3389\/fphys.2019.01630","volume":"10","author":"M Federico","year":"2019","unstructured":"Federico M, Valverde CA, Mattiazzi A, Palomeque J. Unbalance between sarcoplasmic reticulum Ca(2 +) Uptake and Release: A First Step Toward Ca(2 +) Triggered Arrhythmias and Cardiac Damage. Front Physiol. 2019;10:1630. https:\/\/doi.org\/10.3389\/fphys.2019.01630.","journal-title":"Front Physiol"},{"key":"2378_CR14","doi-asserted-by":"publisher","unstructured":"Matuz-Mares D, Gonzalez-Andrade M, Araiza-Villanueva MG, Vilchis-Landeros MM, Vazquez-Meza H. Mitochondrial calcium: effects of its imbalance in disease. Antioxid (Basel). 2022;11. https:\/\/doi.org\/10.3390\/antiox11050801.","DOI":"10.3390\/antiox11050801"},{"key":"2378_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1113\/JP271301","volume":"594","author":"C Vasquez-Trincado","year":"2016","unstructured":"Vasquez-Trincado C, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol. 2016;594:509\u201325. https:\/\/doi.org\/10.1113\/JP271301.","journal-title":"J Physiol"},{"key":"2378_CR16","doi-asserted-by":"publisher","first-page":"587438","DOI":"10.3389\/fphar.2020.587438","volume":"11","author":"W Ding","year":"2020","unstructured":"Ding W, Feng H, Li WJ, Liao HH, Tang QZ. Research progress on the interaction between autophagy and energy homeostasis in cardiac remodeling. Front Pharmacol. 2020;11:587438. https:\/\/doi.org\/10.3389\/fphar.2020.587438.","journal-title":"Front Pharmacol"},{"key":"2378_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15:457\u201370. https:\/\/doi.org\/10.1038\/s41569-018-0044-6.","journal-title":"Nat Rev Cardiol"},{"key":"2378_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.31083\/j.rcm2412364","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Mitochondrial dysfunction in arrhythmia and cardiac hypertrophy. Rev Cardiovasc Med. 2023;24:364. https:\/\/doi.org\/10.31083\/j.rcm2412364.","journal-title":"Rev Cardiovasc Med"},{"key":"2378_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1006\/geno.1999.5881","volume":"60","author":"S Endele","year":"1999","unstructured":"Endele S, Fuhry M, Pak SJ, Zabel BU, Winterpacht A. LETM1, a novel gene encoding a putative EF-hand Ca(2+)-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics. 1999;60:218\u201325. https:\/\/doi.org\/10.1006\/geno.1999.5881.","journal-title":"Genomics"},{"key":"2378_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbamem.2005.02.018","volume":"1711","author":"E Froschauer","year":"2005","unstructured":"Froschauer E, Nowikovsky K, Schweyen RJ. Electroneutral K+\/H\u2009+\u2009exchange in mitochondrial membrane vesicles involves Yol027\/Letm1 proteins. Biochim Biophys Acta. 2005;1711:41\u20138. https:\/\/doi.org\/10.1016\/j.bbamem.2005.02.018.","journal-title":"Biochim Biophys Acta"},{"key":"2378_CR21","doi-asserted-by":"publisher","first-page":"E2249","DOI":"10.1073\/pnas.1308558110","volume":"110","author":"D Jiang","year":"2013","unstructured":"Jiang D, Zhao L, Clish CB, Clapham DE. Letm1, the mitochondrial Ca2+\/H\u2009+\u2009antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome. Proc Natl Acad Sci U S A. 2013;110:E2249\u20132254. https:\/\/doi.org\/10.1073\/pnas.1308558110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2378_CR22","doi-asserted-by":"publisher","first-page":"100988","DOI":"10.1016\/j.gendis.2023.05.005","volume":"11","author":"Y Shi","year":"2024","unstructured":"Shi Y, et al. Aberrant LETM1 elevation dysregulates mitochondrial functions and energy metabolism and promotes lung metastasis in osteosarcoma. Genes Dis. 2024;11:100988. https:\/\/doi.org\/10.1016\/j.gendis.2023.05.005.","journal-title":"Genes Dis"},{"key":"2378_CR23","first-page":"12893","volume":"8","author":"N Li","year":"2015","unstructured":"Li N, et al. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer. Int J Clin Exp Pathol. 2015;8:12893\u2013900.","journal-title":"Int J Clin Exp Pathol"},{"key":"2378_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1242\/dmm.014464","volume":"7","author":"L Hart","year":"2014","unstructured":"Hart L, Rauch A, Carr AM, Vermeesch JR, O\u2019Driscoll M. LETM1 haploinsufficiency causes mitochondrial defects in cells from humans with Wolf-Hirschhorn syndrome: implications for dissecting the underlying pathomechanisms in this condition. Dis Model Mech. 2014;7:535\u201345. https:\/\/doi.org\/10.1242\/dmm.014464.","journal-title":"Dis Model Mech"},{"key":"2378_CR25","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3892\/or.2017.5959","volume":"38","author":"B Huang","year":"2017","unstructured":"Huang B, et al. Suppression of LETM1 by SiRNA inhibits cell proliferation and invasion of bladder cancer cells. Oncol Rep. 2017;38:2935\u201340. https:\/\/doi.org\/10.3892\/or.2017.5959.","journal-title":"Oncol Rep"},{"key":"2378_CR26","doi-asserted-by":"publisher","first-page":"152437","DOI":"10.1016\/j.prp.2019.152437","volume":"215","author":"L Piao","year":"2019","unstructured":"Piao L, et al. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma. Pathol Res Pract. 2019;215:152437. https:\/\/doi.org\/10.1016\/j.prp.2019.152437.","journal-title":"Pathol Res Pract"},{"key":"2378_CR27","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1158\/0008-5472.CAN-08-3235","volume":"69","author":"L Piao","year":"2009","unstructured":"Piao L, et al. Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death. Cancer Res. 2009;69:3397\u2013404. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3235.","journal-title":"Cancer Res"},{"key":"2378_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12885-019-6128-9","volume":"19","author":"L Piao","year":"2019","unstructured":"Piao L, et al. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma. BMC Cancer. 2019;19:898. https:\/\/doi.org\/10.1186\/s12885-019-6128-9.","journal-title":"BMC Cancer"},{"key":"2378_CR29","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.ajhg.2022.07.007","volume":"109","author":"R Kaiyrzhanov","year":"2022","unstructured":"Kaiyrzhanov R, et al. Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. Am J Hum Genet. 2022;109:1692\u2013712. https:\/\/doi.org\/10.1016\/j.ajhg.2022.07.007.","journal-title":"Am J Hum Genet"},{"key":"2378_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1083\/jcb.201303052","volume":"203","author":"AY Rangrez","year":"2013","unstructured":"Rangrez AY, et al. Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy. J Cell Biol. 2013;203:643\u201356. https:\/\/doi.org\/10.1083\/jcb.201303052.","journal-title":"J Cell Biol"},{"key":"2378_CR31","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.1074\/jbc.M116.752543","volume":"292","author":"A Borlepawar","year":"2017","unstructured":"Borlepawar A, et al. TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels. J Biol Chem. 2017;292:10180\u201396. https:\/\/doi.org\/10.1074\/jbc.M116.752543.","journal-title":"J Biol Chem"},{"key":"2378_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson M, et al. Langendorff-Free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ Res. 2016;119:909\u201320. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309202. A Simplified.","journal-title":"Circ Res"},{"key":"2378_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge PW, et al. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014;11:855\u201360. https:\/\/doi.org\/10.1038\/nmeth.2999.","journal-title":"Nat Methods"},{"key":"2378_CR34","doi-asserted-by":"publisher","first-page":"e1900192","DOI":"10.1002\/pmic.201900192","volume":"19","author":"S Blankenburg","year":"2019","unstructured":"Blankenburg S, et al. Improving proteome coverage for small sample amounts: an advanced method for proteomics approaches with low bacterial cell numbers. Proteomics. 2019;19:e1900192. https:\/\/doi.org\/10.1002\/pmic.201900192.","journal-title":"Proteomics"},{"key":"2378_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"2378_CR36","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","journal-title":"Bioinformatics"},{"key":"2378_CR37","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2378_CR38","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innov (Camb)"},{"key":"2378_CR39","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1172\/JCI86080","volume":"126","author":"M Kumari","year":"2016","unstructured":"Kumari M, et al. IRF3 promotes adipose inflammation and insulin resistance and represses Browning. J Clin Invest. 2016;126:2839\u201354. https:\/\/doi.org\/10.1172\/JCI86080.","journal-title":"J Clin Invest"},{"key":"2378_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86080","author":"M Kumari","year":"2016","unstructured":"Kumari M, et al. IRF3 promotes adipose inflammation and insulin resistance and represses Browning. J Clin Investig. 2016. https:\/\/doi.org\/10.1172\/JCI86080.","journal-title":"J Clin Investig"},{"key":"2378_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/em.20586","volume":"51","author":"DC Wallace","year":"2010","unstructured":"Wallace DC. Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen. 2010;51:440\u201350. https:\/\/doi.org\/10.1002\/em.20586.","journal-title":"Environ Mol Mutagen"},{"key":"2378_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1\u201313. https:\/\/doi.org\/10.1042\/BJ20081386.","journal-title":"Biochem J"},{"key":"2378_CR43","doi-asserted-by":"publisher","first-page":"1433102","DOI":"10.3389\/fmmed.2024.1433102","volume":"4","author":"J Dudek","year":"2024","unstructured":"Dudek J, Ritterhoff J, Editorial. Mitochondrial dysfunction affects mechano-energetic coupling in heart failure. Front Mol Med. 2024;4:1433102. https:\/\/doi.org\/10.3389\/fmmed.2024.1433102.","journal-title":"Front Mol Med"},{"key":"2378_CR44","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1172\/JCI27955","volume":"116","author":"GD Barish","year":"2006","unstructured":"Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest. 2006;116:590\u20137. https:\/\/doi.org\/10.1172\/JCI27955.","journal-title":"J Clin Invest"},{"key":"2378_CR45","doi-asserted-by":"publisher","unstructured":"Pol CJ, Lieu M, Drosatos K, PPARs. Protectors or Opponents of Myocardial Function? PPAR Res. 2015;2015:835985. https:\/\/doi.org\/10.1155\/2015\/835985.","DOI":"10.1155\/2015\/835985"},{"key":"2378_CR46","doi-asserted-by":"publisher","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","volume":"8","author":"DH Tran","year":"2019","unstructured":"Tran DH, Wang ZV. Glucose metabolism in cardiac hypertrophy and heart failure. J Am Heart Assoc. 2019;8:e012673. https:\/\/doi.org\/10.1161\/JAHA.119.012673.","journal-title":"J Am Heart Assoc"},{"key":"2378_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/clp.13.75","volume":"9","author":"MR Irvin","year":"2014","unstructured":"Irvin MR, Aslibekyan S, Hidalgo B, Arnett D. CPT1A: the future of heart disease detection and personalized medicine? Clin Lipidol. 2014;9:9\u201312. https:\/\/doi.org\/10.2217\/clp.13.75.","journal-title":"Clin Lipidol"},{"key":"2378_CR48","doi-asserted-by":"publisher","unstructured":"Dorn GW 2nd. Mitochondrial dynamics in heart disease. Biochim Biophys Acta. 2013;1833:233\u201341. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.03.008.","DOI":"10.1016\/j.bbamcr.2012.03.008"},{"key":"2378_CR49","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbamcr.2017.03.006","volume":"1864","author":"J Nan","year":"2017","unstructured":"Nan J, et al. Molecular regulation of mitochondrial dynamics in cardiac disease. Biochim Biophys Acta Mol Cell Res. 2017;1864:1260\u201373. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.03.006.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2378_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198\u2013205. https:\/\/doi.org\/10.1038\/415198a.","journal-title":"Nature"},{"key":"2378_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","volume":"21","author":"PA Gorski","year":"2015","unstructured":"Gorski PA, Ceholski DK, Hajjar RJ. Altered myocardial calcium cycling and energetics in heart failure\u2013a rational approach for disease treatment. Cell Metab. 2015;21:183\u201394. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.005.","journal-title":"Cell Metab"},{"key":"2378_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1161\/01.RES.0000060027.40275.A6","volume":"92","author":"SR Houser","year":"2003","unstructured":"Houser SR, Margulies KB. Is depressed myocyte contractility centrally involved in heart failure? Circ Res. 2003;92:350\u20138. https:\/\/doi.org\/10.1161\/01.RES.0000060027.40275.A6.","journal-title":"Circ Res"},{"key":"2378_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333. https:\/\/doi.org\/10.1038\/s41392-023-01547-9.","journal-title":"Signal Transduct Target Ther"},{"key":"2378_CR54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/ars.2012.4777","volume":"19","author":"SB Ong","year":"2013","unstructured":"Ong SB, Hall AR, Hausenloy DJ. Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal. 2013;19:400\u201314. https:\/\/doi.org\/10.1089\/ars.2012.4777.","journal-title":"Antioxid Redox Signal"},{"key":"2378_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12192-023-01321-4","volume":"28","author":"X Liu","year":"2023","unstructured":"Liu X, Guo C, Zhang Q. Novel insights into the involvement of mitochondrial fission\/fusion in heart failure: from molecular mechanisms to targeted therapies. Cell Stress Chaperones. 2023;28:133\u201344. https:\/\/doi.org\/10.1007\/s12192-023-01321-4.","journal-title":"Cell Stress Chaperones"},{"key":"2378_CR56","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/CIRCRESAHA.117.311082","volume":"120","author":"JM Bravo-San Pedro","year":"2017","unstructured":"Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and mitophagy in cardiovascular disease. Circ Res. 2017;120:1812\u201324. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311082.","journal-title":"Circ Res"},{"key":"2378_CR57","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","volume":"133","author":"A Shirakabe","year":"2016","unstructured":"Shirakabe A, et al. Drp1-Dependent mitochondrial autophagy plays a protective role against pressure Overload-Induced mitochondrial dysfunction and heart failure. Circulation. 2016;133:1249\u201363. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020502.","journal-title":"Circulation"},{"key":"2378_CR58","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","volume":"116","author":"T Saito","year":"2015","unstructured":"Saito T, Sadoshima J. Molecular mechanisms of mitochondrial autophagy\/mitophagy in the heart. Circ Res. 2015;116:1477\u201390. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303790.","journal-title":"Circ Res"},{"key":"2378_CR59","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCRESAHA.108.187427","volume":"104","author":"AB Gustafsson","year":"2009","unstructured":"Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res. 2009;104:150\u20138. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.187427.","journal-title":"Circ Res"},{"key":"2378_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01142-1","author":"R Ravindran","year":"2025","unstructured":"Ravindran R, Gustafsson AB. Mitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing. Nat Rev Cardiol. 2025. https:\/\/doi.org\/10.1038\/s41569-025-01142-1.","journal-title":"Nat Rev Cardiol"},{"key":"2378_CR61","doi-asserted-by":"publisher","first-page":"1446300","DOI":"10.3389\/fphar.2024.1446300","volume":"15","author":"R Bian","year":"2024","unstructured":"Bian R, Zhang L, Li D, Xu X. CDKN1A as a target of senescence in heart failure: insights from a multiomics study. Front Pharmacol. 2024;15:1446300. https:\/\/doi.org\/10.3389\/fphar.2024.1446300.","journal-title":"Front Pharmacol"},{"key":"2378_CR62","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","volume":"63","author":"KC Wollert","year":"2017","unstructured":"Wollert KC, Kempf T, Wallentin L. Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem. 2017;63:140\u201351. https:\/\/doi.org\/10.1373\/clinchem.2016.255174.","journal-title":"Clin Chem"},{"key":"2378_CR63","first-page":"2890","volume":"10","author":"L Yu","year":"2018","unstructured":"Yu L, et al. FoxO4 promotes myocardial ischemia-reperfusion injury: the role of oxidative stress-induced apoptosis. Am J Transl Res. 2018;10:2890\u2013900.","journal-title":"Am J Transl Res"},{"key":"2378_CR64","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1111\/febs.16221","volume":"289","author":"T Gui","year":"2022","unstructured":"Gui T, Burgering BMT. FOXOs: masters of the equilibrium. FEBS J. 2022;289:7918\u201339. https:\/\/doi.org\/10.1111\/febs.16221.","journal-title":"FEBS J"},{"key":"2378_CR65","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4070\/kcj.2019.0416","volume":"50","author":"CM Oh","year":"2020","unstructured":"Oh CM, Ryu D, Cho S, Jang Y. Mitochondrial quality control in the heart: new drug targets for cardiovascular disease. Korean Circ J. 2020;50:395\u2013405. https:\/\/doi.org\/10.4070\/kcj.2019.0416.","journal-title":"Korean Circ J"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02378-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:45:42Z","timestamp":1755920742000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02378-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2378"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02378-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed according to international, institutional and governmental ethical guidelines. LAD mouse experiment was approved by the Ministry of Energy Transition, Agriculture, Environment, Nature and Digitalization (MELUND) of the state of Schleswig-Holstein (96\u2009\u2212\u200911\/20) and ORAB mouse experiment was approved by the authorities of the Regierungspr\u00e4sidium Karlsruhe (G-174\/23). The use of human tissue samples conforms to the declaration of Helsinki and was approved by the ethical committee of the medical school of the Georg-August-University, G\u00f6ttingen. Written informed consent was received from all participants prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}